|
|
Volumn 39, Issue 4, 1997, Pages 361-398
|
|
Pathophysiology and pharmacological approaches for prevention of coronary artery restenosis following coronary artery balloon angioplasty and related procedures
a
a
a
NONE
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABCIXIMAB;
ACETYLSALICYLIC ACID;
ANGIOTENSIN RECEPTOR ANTAGONIST;
ANTICOAGULANT AGENT;
ANTIINFLAMMATORY AGENT;
ANTILIPEMIC AGENT;
ANTINEOPLASTIC AGENT;
ANTIOXIDANT;
ANTITHROMBIN III;
ANTITHROMBOCYTIC AGENT;
CILAZAPRIL;
DEXTRAN;
DIPYRIDAMOLE;
EBSELEN;
ENOXAPARIN;
FISH OIL;
HEPARIN;
HIRUDIN;
KETANSERIN;
OMEGA 3 FATTY ACID;
PLACEBO;
SULFINPYRAZONE;
THROMBOXANE A2;
TICLOPIDINE;
TISSUE PLASMINOGEN ACTIVATOR;
TRANILAST;
TRAPIDIL;
UNINDEXED DRUG;
VASODILATOR AGENT;
WARFARIN;
ARTICLE;
ATHERECTOMY;
CLINICAL TRIAL;
CORONARY ARTERY OBSTRUCTION;
GENE THERAPY;
HUMAN;
NONHUMAN;
PATHOPHYSIOLOGY;
RESTENOSIS;
SUBCUTANEOUS DRUG ADMINISTRATION;
TRANSLUMINAL CORONARY ANGIOPLASTY;
|
|
EID: 0030967964
PISSN: 00330620
EISSN: None
Source Type: Journal
DOI: 10.1016/S0033-0620(97)80034-5 Document Type: Article |
|
Times cited : (58)
|
|
References (355)
|
